⌘K

Login Start Free

Home/Insiders/Sensenig Bethany

SB

SEC Insider//CIK 0001899935

Sensenig Bethany

CIK 00018999353 companiesFRAMINGHAM, MA

Transactions

12

Companies

3

Filings

9

CIK

0001899935

Recent Transactions

12 trades

Award
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (right to buy)
2025-10-01+45,000→ 45,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-14$42.25/sh−5,369→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+5,369→ 5,369 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2025-02-22−5,369→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,475→ 4,475 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2024-02-22+5,369→ 5,369 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2023-08-17+24,153→ 24,153 total
Sale
9 METERS BIOPHARMA, INC.
Common stock
2023-04-21$1.21/sh−9,100→ 41,077 total
Award
9 METERS BIOPHARMA, INC.
Common Stock
2023-03-27+50,177→ 50,177 total
Award
9 METERS BIOPHARMA, INC.
Stock Option (Right to Buy)
2022-01-18+1,300,000→ 1,300,000 total

Companies

3

Recent Filings

9

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov